Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Current Gastroenterology Reports|September 14, 2002
HIV1 and the gut in the era of highly active antiretroviral therapyEsteban C Nannini, Pablo C OkhuysenExpert Opinion on Pharmacotherapy|August 2, 2008
A new lipoglycopeptide: telavancinEsteban C Nannini, Martin E StryjewskiThe Journal of Infectious Diseases|January 6, 2005
Importance of gls24 in virulence and stress response of Enterococcus faecalis and use of the Gls24 protein as a possible immunotherapy targetFang Teng, Esteban C Nannini, Barbara E MurrayExpert Opinion on Pharmacotherapy|April 21, 2010
Ceftaroline for complicated skin and skin-structure infectionsEsteban C Nannini, Martin E Stryjewski, G Ralph CoreyClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2003
Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issueEsteban C Nannini, Kavindra V Singh, Barbara E MurrayExpert Review of Anti-Infective Therapy|October 4, 2012
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studiesEsteban C Nannini, G Ralph Corey, Martin E StryjewskiDiagnostic Microbiology and Infectious Disease|May 14, 2003
Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literatureEsteban C Nannini, Niki I Paphitou, Luis Ostrosky-ZeichnerFuture Microbiology|March 10, 2010
Telavancin's interactions with the bacterial cell membraneEsteban C Nannini, Martin E Stryjewski, G Ralph CoreyMedicina|October 11, 2022
Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremiaMora N Obed, Inés Toresani, Analía Mykietuk, et al.Infection and Immunity|October 22, 2005
Decreased virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experimental endocarditis modelEsteban C Nannini, Fang Teng, Kavindra V Singh, et al.Pageof 4